Western Health Advantage
Revlimid (lenalidomide)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limit: limit maximum 1 EA PER 1 day(s)
  • ST_APPLIES
  • Melanoma (MEL):
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    NSCLC with BRAF Mutation:
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Thyroid Carcinoma:
    Duration: 1 year(s)

  • QL (2 per Rx);
<< Return | Back to top